Chondroitin
CAS number： 9007-28-7
Molecular formula： C13H21NO16S
molecular weight： 479.36800
Chemical structure：
Producers shown on SFDA
(Record date:31/08/2021）
Producer | Documents | GMP Valid till(based on SFDA) |
| Jiangsu Puhua Kesheng Pharmaceutical Co., Ltd. | GMP | Valid till May 2023 |
Sichuan Beiao Bbiopharmaceutical Co., Ltd. | GMP | Valid till September 2019 |
Rizhao Lanshan Biochemical products Co., Ltd. | GMP | Valid till July 2022 |
Yantai Dongcheng Pharmaceutical Group Co., Ltd. | GMP, HALAL | Valid till August 2022 |
Qingdao Kangyuan Pharmaceutical Co., Ltd. | GMP | Valid till January 2021 |
Sichuan Deebio Pharmaceutical Co., Ltd. | GMP | Valid till January 2023 |
Chongqing Aoli biopharmaceutical Co., Ltd. | GMP | Valid till November 2024 |
Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. | GMP | Valid till July 2023 |
Chengdu Tiantai Mount Pharmaceutical Co., Ltd. | GMP | Valid till April 2020 |
Sichuan Friendly Pharmaceutical Co., Ltd. | GMP | Valid till November 2019 |
Hubei Lujinzi Pharmaceutical Co., Ltd. | GMP | Valid till January 2021 |
Producers shown on EP
(Quoted from EP website；record date:31/08/2021）
| Substance | Certificate Holder | Certificate Number | Issue Date | Status | End date | Type |
| Chondroitin sulfate sodium Terrestrial avian origin | ROVAFARM ARGENTINA S.A. AR 1763 Buenos Aires | R1-CEP 2007-058-Rev 01 | 19/11/2020 | VALID | / | Chemistry |
| Chondroitin sulfate sodium Non-European Origin | BIOIBERICA, S.A.U. ES 08389 Palafolls | R1-CEP 2001-063-Rev 04 | 19/12/2019 | VALID | / | TSE |
| Chondroitin sulfate sodium | Jiangyin TSI Pharmaceutical Co., Ltd. CN 214 446 Jiangyin | R1-CEP 2006-063-Rev 02 | 13/07/2015 | VALID | / | TSE |
| Chondroitin Sulfate | N.V. ORGANON NL 5349 AB Oss | R1-CEP 2000-327-Rev 01 | 21/02/2007 | WITHDRAWN BY HOLDER | 07/11/2011 | TSE |
| Chondroitin sulfate sodium | Solabia FR 93698 Pantin | R1-CEP 2000-220-Rev 02 | 25/07/2012 | VALID | / | TSE |
| Chondroitin sulfate sodium Terrestrial origin | BIOIBERICA, S.A.U. ES 08389 Palafolls | R1-CEP 2006-209-Rev 03 | 19/12/2019 | VALID | / | Double |
| Chondroitin sulfate sodium Terrestrial origin | Yantai Dongcheng Biochemicals Co., Ltd. CN 264 006 Yantai | R1-CEP 2006-242-Rev 02 | 20/07/2017 | VALID | / | Double |
| Chondroitin sulfate sodium Terrestrial origin | INTERNACIONAL FARMACEUTICA ARGENTINA S.A. AR 1440 Buenos Aires City | R1-CEP 2007-030-Rev 02 | 03/11/2016 | VALID | / | Double |
| Chondroitin sulfate sodium | TANGSHAN SANXIN BIOCHEMICAL PRODUCTS CO., LTD. CN 063 100 Tangshan City | R0-CEP 2011-217-Rev 00 | 27/08/2013 | EXPIRED | 06/09/2018 | TSE |
| Chondroitin sulfate sodium | Syntex S.A. AR B1838DQK Buenos Aires | R1-CEP 2006-179-Rev 01 | 04/09/2017 | VALID | / | TSE |
| Chondroitin sulfate sodium | SIOUX PHARM, INC. US 51250 Sioux Center | R1-CEP 2009-218-Rev 00 | 31/08/2016 | VALID | / | TSE |
| Chondroitin sulfate sodium | SHANDONG ZHONGYUAN GREENTECH CO., LTD. CN 251 601 Jinan | R1-CEP 2011-281-Rev 00 | 28/08/2018 | VALID | / | TSE |
| Chondroitin sulfate sodium European origin | BIOIBERICA, S.A.U. ES 08389 Palafolls | R1-CEP 2007-197-Rev 02 | 27/03/2019 | VALID | / | TSE |
| Chondroitin sulfate sodium Terrestrial bovine origin | ROVAFARM ARGENTINA S.A. AR 1763 Buenos Aires | R1-CEP 2007-059-Rev 04 | 23/11/2020 | VALID | / | Double |
Producer:Jiangsu Puhua Kesheng Pharmaceutical Co., Ltd., a subsidiary of Jiyao holding group, mainly produces a series of chemicals, Chinese patent medicines, biochemical drugs and APIs. It is a large-scale and modern medical and health industry base.
Jiangsu Puhua Kesheng Pharmaceutical Co., Ltd., founded in 1970, is a high-tech enterprise in Jiangsu Province. The company has production facilities, equipment and workshops in line with GMP standards, producing 7 dosage forms and 39 varieties of APIs such as eye drops, tablets, capsules, granules, oral solutions, syrups and tinctures, forming a product portfolio of traditional Chinese medicine, chemical medicine and biochemical medicine.
Producer:Founded in 1970, Sichuan Beiao Biopharmaceutical Co., Ltd. specializes in the research and production of biochemical and pharmaceutical raw materials, Pancreatin and other products have been exported to Europe, America, Southeast Asia and other more than ten countries and regions for many years, and have developed into a large-scale pancreatin production base in China. At present, the annual output of the leading product trypsin is 150 tons and chondroitin sulfate is 50 tons.
Staff size:50-99 persons
Registered capital:RMB 5.4752 million
Producer:Rizhao Lanshan biochemical products Co., Ltd. is a wholly foreign-owned enterprise invested and established by IBSA biochemical company of Switzerland. All products are exported. It is an important production base of IBSA in China. Founded in 2002 with a registered capital of US $1256700, the company is located in the export processing zone, Lanshan District, Rizhao City, covering a total area of 21331m2. So far, two GMP standardized production workshops and one GLP standardized laboratory have been built, and the CNAs accreditation of the laboratory is in the document review stage.
The company's main products: chondroitin sulfate API (CS), human menopausal gonadotropin (HMG), human chorionic gonadotropin (hCG), etc., of which 2 are advanced in the world and 1 is leading in China.
Staff size:50-99 persons
Registered capital:USD 1 million 256 thousand and 700
Producer:Yantai Dongcheng Pharmaceutical Group Co., Ltd. (formerly Yantai Dongcheng Biochemical Co., Ltd.) was established in 1998 and listed on Shenzhen Stock Exchange in May 2012. As a leading biochemical API manufacturer in China, Dongcheng pharmaceutical's core products heparin sodium and chondroitin sulfate have won the certification of many international authorities with excellent quality. More than 90% of its products are sold to more than 40 countries and regions around the world, such as Europe, America and Asia Pacific, and has established long-term and stable cooperative relations with many international well-known pharmaceutical enterprises.
Staff size:2000 persons
Registered capital:RMB 802 million 200 thousand
Producer:Qingdao Jiulong Biopharmaceutical Co., Ltd. is a high-tech biochemical pharmaceutical enterprise with modern management and production integrating scientific research, production and sales. It is recognized as a high-tech enterprise by the state. With strong engineering and technical personnel, it has unique advantages in separation technology and purification technology to ensure the high quality of products in the production process.
The company covers a total area of 125000 square meters and a total construction area of 20000 square meters. The product quality complies with USP, British Pharmacopoeia , Chinese Pharmacopoeia and European Pharmacopoeia.
Staff size:About 50 persons
Registered capital:RMB 100 million
Producer:Sichuan Deebio Pharmaceutical Co., Ltd., established through transformation and upgrading from the former Sichuan Deyang biochemical products Co., Ltd. (founded in 1995), is a wholly-owned subsidiary of Sichuan debor Biotechnology Co., Ltd. and a national high-tech enterprise.
The quality has reached the world leading level, exported to Europe, the United States, South America, India, Russia, South Korea, Japan and other countries and regions, and occupies an important position in the global biological enzyme API market.
Staff size:200-299 persons
Registered capital:RMB 20 million
Producer:Founded in August 1996 and renamed Chongqing Aoli Biopharmaceutical Co., Ltd. in 2003, the company is a national high-tech enterprise and a municipal science and technology enterprise.
The company passed the new version of GMP certification in November 2019. The production plant is designed and built in strict accordance with the national GMP standards. The existing production plant is more than 7200 square meters and office and other supporting rooms are more than 3000 square meters. There are 3 API production lines, 1 tablet production line, 1 capsule production line and 1 granule production line; The annual output of API is 500 tons. The leading products include trypsin, pepsin, gastrin, sodium chondroitin sulfate, etc. the product quality meets the standards of CP, USP, EP, BP and JP, and is exported to America, Europe, Southeast Asia and other regions; Annual production capacity of preparations: 2 billion tablets, 1 billion capsules and 1 billion bags of granules. The varieties of preparations produced include multienzyme tablets, pepsin tablets, elastase enteric coated tablets, pancreatin enteric coated capsules, etc.
Producer:Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. is a leading production and operation enterprise of polysaccharide and protease drugs in the domestic biochemical pharmaceutical industry, a national high-tech enterprise and a key backbone enterprise of the national three drug base. It has won the title of national, provincial and municipal drug quality integrity demonstration enterprise for many consecutive years. It was successfully listed on Shenzhen Stock Exchange on February 18, 2011.
The total investment of the company is 120 million yuan, covering an area of 73260 square meters and a construction area of 20000 square meters. It is composed of comprehensive production workshop, administrative center, research and development center, Quality Assurance Center, etc. The whole plant is designed and built according to GMP standards, and the greening area accounts for 60% of the total area of the plant. It mainly produces freeze-dried powder injection (including antitumor drugs), small volume injection, tablet, capsule and API. Representative products include trypkininogenase, trypsin elastase, L-asparaginase, heparin sodium, etc. All products have passed GMP certification.
Staff size:About 1500 persons
Registered capital:RMB 1 billion 280 million
Producer:Chengdu Tiantai Mount Pharmaceutical Co., Ltd. is a high-tech pharmaceutical enterprise established in 1993. The company is located in the beautiful northern suburb of Qionglai City, covering an area of 300 mu and a construction area of more than 65000 square meters.
The company has freeze-dried powder injection, small volume injection, tablet, capsule, granule and API production lines. Among them, the scale and production capacity of freeze-drying production line are among the best among national pharmaceutical enterprises, and the annual production capacity of freeze-drying powder injection and small volume injection production lines are 300 million bottles and 500 million tubes respectively. The company produces 108 varieties and 175 specifications of preparations, including 16 APIs.
Staff size:About 10000 persons
Producer:After 30 years, Sichuan Friendly Pharmaceutical Co., Ltd. has developed into a large-scale and scientific and technological pharmaceutical enterprise integrating the development, production and operation of biochemical API and Chinese and Western pharmaceutical preparations. It passed the GMP certification in June 2004. The GMP production base newly built by our company in 2004 covers an area of 45000 square meters and a construction area of more than 20000 square meters. At present, there are five dosage forms of tablets, capsules, granules, syrups and powders, and eight APIs such as trypsin, pepsin, gastromodulin and artificial bezoar.
Registered capital:RMB 35 million
Producer:Hubei Lujinzi Pharmaceutical Co., Ltd.，founded in the early 1970s, is a key backbone enterprise of wuchangyu group. All production plants and dosage forms of the company have passed the national GMP certification. The products are both Chinese and Western medicine, covering tablets, granules, hard capsules, syrups, APIs, oral solutions, lotions, class II medical devices, health products More than 10 series of food and more than 100 product specifications.
Staff size:About 50 persons
Registered capital:RMB 31.3 million
For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978
Tel: Cell/WhatsApp/WeChat: +86 18402846978
Email: paulzhang@yinuopharmchem.com
SKYPE